Jennifer Bright - Jun 2, 2023 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Chief Financial Officer
Signature
/s/ Michael C. Carroll, attorney-in-fact for Jennifer Bright
Stock symbol
BIOL
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2023, 08:29 PM
Previous filing
Aug 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +58K +178.12% $0.00 90.6K Jun 2, 2023 Common Stock 58K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on May 9, 2024, and (ii) one-half of the restricted stock units shall vest on May 9, 2025, subject to the Reporting Person's continued service with the Company.
F3 The restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on the twelve-month anniversary of date of grant, and (ii) one-half of the restricted stock units shall vest on the twenty-fourth month anniversary of the date of grant, subject to the Reporting Person's continued service with the Company.